Quiz Finale M3 — SaaS DD Memo Completo

Investment Memo Template — Prisma Analytics S.r.l.

Executive Summary

Target: Prisma Analytics S.r.l. — B2B SaaS HR analytics platform (talent retention prediction, turnover forecasting, workforce planning)

Ask: Series B, €8M equity @ €42M post-money (10x ARR)

Recommendation: INVEST — Strong unit economics, best-in-class NRR, capital-efficient growth, clear path to Rule of 40

Key Metrics Snapshot:

Thesis: Prisma combina NRR top-tier (108%) con unit economics eccezionali (CAC Payback 9 mesi, LTV/CAC 16x). Growth è below median (35% vs 60-80%) ma giustificato da TAM focus (HR analytics vertical) e go-to-market deliberatamente capital-efficient. Path to Rule of 40 è chiaro: mantenendo growth 30% e raggiungendo break-even EBITDA nei prossimi 18 mesi (riduzione S&M di 10-15pp), Rule of 40 sale a 45+.

Risks: (1) Growth deceleration (da 50% a 35% negli ultimi 12 mesi), (2) Competitive pressure da incumbents (Workday, SAP SuccessFactors entrano in predictive analytics), (3) Sales cycle lungo (6-9 mesi enterprise deals).

Valuation: 10x ARR (€42M) è fair per Series B con NRR >100% e CAC payback <12 mesi. Comparable: SaaS €3-10M ARR, NRR >100%, growth 30-50% trade a 8-12x ARR (KeyBanc 2024). Downside protection: anche a 7x ARR (bearish scenario), downside limitato a -30%.

Exit Scenario (5Y): ARR cresce a 25% CAGR (conservative) → €12.600K ARR Y5. Exit multiple 12x (assume market normalization) → EV €151M. Equity value post-dilution (assume 20% dilution Series C/D): €120M. MOIC: €120M / €8M = 15x (~72% IRR). Downside case (20% CAGR, 8x exit): MOIC 6,5x (~45% IRR).

---

Section 1 — Business Model & Market

Product

Prisma è una piattaforma SaaS per HR analytics predittivo. Target: aziende 500-5.000 dipendenti (mid-market enterprise). Use case principale: employee churn prediction.

Come funziona:

1. 01Integrazione con HRIS (Workday, SAP, BambooHR) → pull employee data (tenure, salary, performance reviews, engagement surveys)
2. 02ML model analizza pattern storici di turnover
3. 03Dashboard predittivo: "Employee X ha 78% probabilità di lasciare nei prossimi 6 mesi"
4. 04Actionable insights: retention playbook personalizzato (salary adjustment, role change, manager coaching)

Revenue model:

• •Platform fee: €1.500/mese base (fino a 500 employees)
• •Per-employee tier pricing: +€2/employee/mese oltre 500 employees
• •Average customer: 1.200 employees → €1.500 + (700 × €2) = €2.900/mese = €34.800/anno ARPU

Retention mechanics:

• •Contratti annual (80% base) o monthly (20%)
• •Churn drivers: (1) Budget cuts HR tech, (2) M&A (acquirer ha tool interno), (3) ROI non provato (prediction accuracy <70%)
• •Expansion drivers: (1) Headcount growth del cliente, (2) Add-on modules (workforce planning, diversity analytics)

TAM (Total Addressable Market)

Top-down:

• •EU companies 500-5.000 employees: ~180.000 (Eurostat 2023)
• •% con HRIS digitale (prerequisito per Prisma): ~40% = 72.000
• •ARPU €35K → TAM = 72.000 × €35K = €2,5 miliardi

Bottom-up (realistico):

• •Prisma oggi: 120 clienti, €4.200K ARR
• •Pipeline activo: 300 prospect (qualified)
• •Conversion rate storico: 25% → 75 new customers/anno
• •Ceiling a current pricing/GTM: ~1.500 clienti (€52M ARR) prima di saturare mid-market EU

Market dynamics:

• •Competitive landscape: Fragmented. No incumbent dominante. Workday/SAP hanno analytics ma non predittivo. Startup competitors (Visier, ChartHop, Orgnostic) si concentrano su descriptive analytics, non predictive.
• •Prisma differentiator: Prediction accuracy 82% (validated) vs 65-70% competitors. Playbook automation (non solo dashboard — azioni consigliate).
• •Threat: Workday/SAP potrebbero buildare predittivo in-house o acquire competitor. Prisma ha 18-24 mesi di lead tech prima che incumbents chiudano gap.

---

Section 2 — Financial Analysis

ARR Build & Growth

ARR Bridge FY2024:

New ARR (new customers) +€1.050K (90 new customers × €35K ARPU × (12/12))

Expansion ARR (existing) +€220K (upsell moduli, headcount growth clienti)

Churned ARR -€150K (8 customers lost × avg €18.750 ARR)

Contraction ARR -€20K (downgrade tier, headcount reduction)

Net New ARR +€1.100K ──────────────────────────────────────────── ARR End (31 Dec 2024) €4.200K

Component analysis:

• •New ARR €1.050K: 90 new customers × €11.667 avg ARR = €1.050K. (Nota: €11.667 < €35K ARPU perché molti new customers sono SMB tier con <500 employees → lower ARPU)
• •Expansion ARR €220K: €220K / €3.100K base = 7,1% expansion rate. Buono ma non eccezionale (benchmark top quartile: 10-15%).
• •Churn ARR €150K: €150K / €3.100K = 4,8% gross revenue churn (annualized). Ottimo (<10% target).
• •NRR = (€3.100K + €220K - €150K - €20K) / €3.100K = €3.150K / €3.100K = 101,6%. (Nota: questo non matcha il 108% dichiarato — investigare discrepancy).

Discrepancy investigation:

Management dichiara NRR 108% ma ARR bridge implica 101,6%. Possibile causa:

1. 01Cohort-based NRR vs point-in-time: NRR 108% potrebbe essere calcolato su cohort FY2023 (clienti attivi a Jan 2023, misurati a Jan 2024). Il 101,6% è based su total ARR base.
2. 02Expansion timing: se expansion ARR include upsell chiusi a Dic 2024 ma non ancora riflessi in ARR snapshot, c'è lag.

Action: richiedi NRR calculation methodology e cohort analysis. Se NRR reale è 108%, aspettati expansion ARR ~€248K (non €220K).

Growth deceleration:

• •FY2023: ARR growth 50% (da €2.067K a €3.100K)
• •FY2024: ARR growth 35,5% (da €3.100K a €4.200K)

Causa: Sales headcount non è cresciuto in linea con ARR. FY2023: 6 AE (account executives). FY2024: 8 AE (+33%). Revenue per AE è salito da €517K a €525K (+1,5%) → productivity flat. Per mantenere 50% growth servivano 10-12 AE.

Management explanation: "Deliberate deceleration — prioritizziamo capital efficiency su hypergrowth. Preferiamo 35% growth sostenibile con CAC Payback <12 mesi vs 60% growth con CAC Payback 18-24 mesi."

Implication: se il fondo vuole re-accelerate a 50-60% growth, serve +€600K S&M spend (+4 AE, +2 SDR) → Adjusted EBITDA peggiora di €600K nel Y1, ma ARR growth sale a 50%+.

Revenue & Profitability

P&L FY2024:

Total Revenue                      €4.200K
  Subscription (94%)                €3.950K

Cost of Revenue (840K) Subscription CoR (650K) Services CoR (190K) ──────────────────────────────────────────── Gross Profit €3.360K Blended GM: 80% Subscription GM: 84% (best-in-class) Services GM: -24% (loss leader)

R&D (1.100K) of which Stock Comp (320K) R&D ex-stock: €780K (18,6% revenue)

S&M (1.500K) of which Stock Comp (180K) S&M ex-stock: €1.320K (31,4% revenue)

G&A (580K) of which Stock Comp (95K) G&A ex-stock: €485K (11,5% revenue) ──────────────────────────────────────────── EBITDA (GAAP) (730K) Margin: -17,4%

Stock-Based Compensation (total) (595K) (14,2% revenue) ──────────────────────────────────────────── Adjusted EBITDA (135K) Margin: -3,2% ```

Observations:

1. 01Gross Margin 84% (subscription) is best-in-class. Benchmark: Bessemer median 75-80%. Prisma è top quartile. Drivers: (a) Low hosting costs (analytics platform, no heavy compute), (b) Minimal customer support (self-service product).

1. 02Services Margin -24% (loss leader). €250K revenue, €190K cost → losing €40K annually su services. Strategically acceptable: services sono onboarding clients (<6% total revenue). Senza services, churn sarebbe higher.

1. 03R&D 18,6% revenue (ex-stock). Benchmark: Series B SaaS median 20-25%. Prisma è below median — underinvesting in product? Management: "Core ML model è maturo. R&D focus su integrations (new HRIS) e add-on modules." Acceptable se product-market fit è strong.

1. 04S&M 31,4% revenue (ex-stock). Benchmark: Series B 35-45%. Prisma è below median — capital-efficient GTM. Confirms deceleration è deliberata.

1. 05Stock Comp 14,2% revenue. Benchmark: 10-15%. Prisma è top range but acceptable.

1. 06Adjusted EBITDA -3,2%. Nearly break-even. Path to profitability: cut S&M 10pp (da 31% a 21% revenue) → Adjusted EBITDA +€420K → +7% margin positive.

Cash Flow & Working Capital

Cash Flow Statement FY2024:

EBITDA (GAAP) -€730K + Stock Comp (non-cash) €595K +/- Working Capital changes +€180K Δ AR: -€120K (AR increased — clients pay slower) Δ Deferred Revenue: +€300K (more upfront billing) ──────────────────────────────────────────── Operating Cash Flow +€45K OCF Margin: +1,1%

CapEx -€30K (laptops, office equipment) ──────────────────────────────────────────── Free Cash Flow +€15K FCF Margin: +0,4%

Key insight: Prisma è FCF positive (appena, +€15K). Per SaaS growth-stage questo è raro. Drivers: (1) Deferred revenue growth €300K (clients pay annual upfront), (2) Stock comp €595K non-cash.

Deferred Revenue analysis:

• •Deferred Revenue end FY2024: €1.100K
• •Deferred Revenue end FY2023: €800K
• •Δ Deferred: +€300K

Benchmark: se 80% clienti pagano annual upfront, deferred dovrebbe essere ~40-50% ARR. Prisma è 26% → implica che molti clienti pagano quarterly o monthly (non tutti annual).

Action: chiedi billing terms breakdown: % annual vs quarterly vs monthly. Se il mix sta shiftando verso monthly, è red flag (meno commitment).

---

Section 3 — Unit Economics

CAC (Customer Acquisition Cost)

Calculation:

S&M Spend FY2024 (ex-stock) €1.320K New Customers FY2024 90 ──────────────────────────────────────────── CAC (blended) = €1.320K / 90 = €14.667

ARPU (avg) = €4.200K ARR / 120 customers = €35.000/anno ──────────────────────────────────────────── CAC/ARPU ratio = €14.667 / €35.000 = 0,42x

Wait — management dichiara CAC Payback 9,2 mesi. Perché discrepancy?

Investigation:

Management usa fully-loaded CAC (include stock comp):

S&M Spend (include stock) €1.500K CAC fully-loaded = €1.500K / 90 = €16.667 CAC Payback = €16.667 / €2.333 = 7,1 mesi

Still not 9,2 mesi. Altra possibile causa: new customer ARPU ≠ average ARPU.

Se i new customers sono prevalentemente SMB (<500 employees), ARPU potrebbe essere €24K (non €35K).

Closer. Assumendo new customer ARPU €24K e CAC fully-loaded €16.667 → payback ~10 mesi (arrotondato a 9,2 con adjustments).

Implication: Prisma sta landando clienti più piccoli (SMB) con lower ARPU. Poi li espande (upsell modules, headcount growth). Questa è land-and-expand strategy classica.

Benchmark CAC Payback 9,2 mesi: Best-in-class (<12 mesi). Top quartile SaaS: 8-14 mesi. Prisma è eccellente.

LTV (Lifetime Value)

Calculation:

ARPU (new customers) €24.000/anno Gross Margin 80% Gross Revenue Churn (annual) 9% ──────────────────────────────────────────── LTV = (€24.000 × 80%) / 9% = €19.200 / 0,09 = €213.333

Benchmark: Good >3x, Best-in-class >5x. Prisma è exceptional (12,8x).

Sensitivity analysis:

Anche nello scenario pessimista (churn 15%), LTV/CAC è 7,7x → still excellent.

Downside protection: unit economics sono talmente forti che anche se churn raddoppia (da 9% a 18%), LTV/CAC resta >6x (acceptable).

Magic Number

Calculation:

ARR Q4 2024 €4.200K ARR Q3 2024 (estimated) €3.950K ──────────────────────────────────────────── Net New ARR Q4 = €250K

S&M Spend Q3 (ex-stock) €330K ──────────────────────────────────────────── Magic Number = €250K / €330K = 0,76

Prisma è 0,76 → borderline acceptable ma below target.

Management explanation: "Q4 aveva holiday season (Nov-Dec slow). Q1-Q3 average Magic Number è 1,1."

Action: richiedi quarterly Magic Number trend ultimi 8 quarters. Se Q1-Q3 è davvero 1,1 e solo Q4 è 0,76 per seasonality, acceptable. Se trend è decrescente (1,5 → 1,2 → 0,9 → 0,76), è red flag (S&M efficiency sta peggiorando).

---

Section 4 — Retention & Expansion

Net Revenue Retention (NRR)

Management disclosed: 108%

Cohort analysis richiesta:

Observations:

1. 01NRR sta decelerando: 2020 cohort (115%) → 2023 cohort (106%). Possibile causa: (a) Early cohorts erano enterprise-heavy (higher ARPU, più expansion), (b) Recent cohorts sono SMB-heavy (lower expansion potential).

1. 02Average cohort NRR 111,5% è diverso dal point-in-time NRR 108% disclosed. Management usa dollar-weighted NRR (pesa cohort per ARR size) → cohort più grandi (2022-2023) pesano di più e hanno NRR più basso → average weighted scende a 108%.

Benchmark NRR 108%: Bessemer best-in-class >110%. Prisma è top quartile.

Expansion drivers breakdown:

• •Headcount growth cliente: 60% dell'expansion (€132K). Se cliente passa da 1.000 a 1.200 employees (+20%), ARR sale proporzionalmente.
• •Upsell moduli: 35% (€77K). Add-on modules (diversity analytics €500/mese, workforce planning €800/mese).
• •Seat expansion: 5% (€11K). More HR users access platform.

Churn analysis by segment:

Insight: SMB churn è alto (18% logo, 12% revenue). Mid-market ed Enterprise sono sticky (3-6% churn). Implicazione: Prisma dovrebbe upmarket — focus su mid-market/enterprise, reduce SMB new customer acquisition.

Action: Se Prisma aumenta avg deal size target da €24K a €40K (focus mid-market), CAC potrebbe salire a €25K ma churn scende a 6% → LTV sale a €267K → LTV/CAC migliora da 12,8x a 10,7x. Net positive perché churn ridotto compensa CAC increase.

---

Section 5 — SaaS Efficiency Metrics

Rule of 40

ARR Growth Rate                      35,5%
EBITDA Margin (Adjusted)             -3,2%
────────────────────────────────────────────

Below target (40). Gap: -7,7pp.

Path to Rule of 40:

Option 1: Growth priority (maintain 35% growth, improve margin)

• •Cut S&M by 10pp (da 31% a 21% revenue) → saves €420K
• •Adjusted EBITDA da -€135K a +€285K (+6,8% margin)
• •Rule of 40 = 35% + 6,8% = 41,8 ✓

Option 2: Margin priority (sacrifice growth, maximize profitability)

• •Cut S&M by 20pp → saves €840K
• •Adjusted EBITDA +€705K (+16,8% margin)
• •But growth slows to 20-25%
• •Rule of 40 = 22% + 16,8% = 38,8 ✗ (still below)

Recommendation: Option 1 — mantenere growth 30-35%, raggiungere break-even EBITDA (+5-7% margin). Rule of 40 sale a 40-42. Questa è la formula standard per Series B → Series C (growth + unit economics → profitability).

Timeline: 18 mesi. Y1 post-investment: taglia S&M 5pp → Adjusted EBITDA -1%. Y2: taglia altri 5pp → +6% margin. Rule of 40 hits 41.

Burn Multiple

FY2024:

Net Burn (EBITDA + stock comp)      -€135K
Net New ARR                         €1.100K
────────────────────────────────────────────
Burn Multiple = €135K / €1.100K = 0,12x

Prisma è 0,12x → exceptional. Brucia solo €0,12 per ogni €1 di new ARR. Top 5% di SaaS.

Implication: se il fondo vuole reinvestire in growth (aumentare S&M), Prisma può permetterselo senza distruggere capital efficiency. Anche raddoppiando burn (da €135K a €270K), burn multiple resta 0,25x (still excellent).

ARR per FTE

ARR                                 €4.200K
FTE (headcount)                          28
────────────────────────────────────────────
ARR/FTE = €4.200K / 28 = €150K per employee

Benchmark: Series B median €120-180K. Prisma è in range (median).

Breakdown per function:

Sales productivity €420K/FTE è buono (target €300-500K). R&D è nella media. G&A ha high ARR/FTE perché è lean team (solo 6 people per finance, legal, ops).

---

Section 6 — Competitive & Market Position

Competitive Landscape

Prisma differentiation:

1. 01Prediction accuracy 82% (validated by 3rd party). Competitors: 65-70%.
2. 02Playbook automation: Not just "Employee X likely to churn" → "Here's the 3-step retention playbook (salary benchmark, role change options, manager coaching script)."
3. 03EU-first: GDPR-native, data residency EU. US competitors (Visier, ChartHop) hanno compliance friction con EU enterprise.

Competitive moat:

• •Data moat (weak): Prisma non ha proprietary dataset. Ogni cliente usa own HRIS data → no network effects.
• •Tech moat (medium): ML model è 2 anni ahead di competitors ma non impossible to replicate.
• •GTM moat (weak): No distribution advantage. Ogni deal è ground-up sales.

Threat analysis:

Scenario 1: Workday builds predictive in-house

Probability: 60% (next 24 months). Workday ha data, distribution, brand. Se buildano predictive analytics con 75% accuracy (vs Prisma 82%), molti clienti usano Workday prediction perché "good enough" e già integrato.

Mitigation: Prisma deve (1) Deepen integrations con Workday (diventa "Workday app" invece di competitor), (2) Espandere TAM oltre HRIS (aggiungere recruiting analytics, compensation benchmarking) → diventa "talent intelligence suite" non solo churn prediction.

Scenario 2: SAP/Oracle acquire competitor (Visier o ChartHop)

Probability: 40%. Se SAP acquisisce Visier per $500M-1B, Visier diventa default analytics per SAP SuccessFactors installed base (30K+ enterprise customers).

Mitigation: Prisma deve accelerare land Enterprise clienti prima che incumbents consolidino. Target: 50+ enterprise logo (>2K employees) nei prossimi 18 mesi → crea switching cost.

Scenario 3: Market fragmentation (no clear winner)

Probability: 50%. HR analytics resta fragmented come Marketing analytics (no dominant player, 20+ tools coexist).

Implication: Prisma può build €50-100M ARR business senza winning entire market. Exit via acquisition da PE/strategic a 10-15x ARR.

---

Section 7 — Investment Recommendation

Valuation Analysis

Proposed Terms:

• •Investment: €8M Series B
• •Post-money valuation: €42M
• •Ownership: 19% (€8M / €42M)
• •Implied ARR multiple: €42M / €4.200K = 10x ARR

Comparable Valuation (SaaS Series B, €3-10M ARR, NRR >100%):

Prisma vs Comps:

• •Growth 35% vs median 65%: -30pp → discount -20% = 0.8x
• •NRR 108% vs median 111%: -3pp → discount -5% = 0.95x
• •CAC Payback 9m vs median 12-15m: Best-in-class → premium +10% = 1.1x

Verdict: 10x ARR è fair value. Non è cheap (discount per growth below median è compensato da unit economics exceptional).

Downside protection:

• •Bearish scenario (growth slows to 20%, NRR drops to 100%): valuation 7x ARR → downside -30%
• •Base case (growth 30-35%, NRR 105-110%): valuation 10-12x → upside 0-20%
• •Bull case (re-accelerate growth to 50%, NRR 115%): valuation 15x → upside +50%

Risk/reward: Asymmetric upside (bull case +50%) vs limited downside (bear -30%). Acceptable per Series B.

5-Year Exit Model

Assumptions:

• •ARR CAGR: 30% (conservative vs current 35%)
• •EBITDA margin Y5: +12% (达到 SaaS median mature)
• •Exit multiple: 12x ARR (market normalization)
• •Dilution: 25% (Series C + D)

Model:

ARR Y0 (2024)                       €4.200K

EBITDA Y5 @ 12% margin €1.814K

Debt (assume zero) €0 ──────────────────────────────────────────── Equity Value (pre-dilution) €181.440K

Dilution 25% (Series C/D) -€45.360K ──────────────────────────────────────────── Equity Value (post-dilution) €136.080K

Investment = €8.000K ──────────────────────────────────────────── MOIC = €19.391K / €8.000K = 2,42x IRR = 19,4% ```

Sensitivity Analysis:

Base case (30% CAGR, 12x exit): 2,42x MOIC, 19,4% IRR → meets fund target (18-25% IRR).

Downside case (25% CAGR, 10x exit): 1,68x MOIC, 10,9% IRR → below target but not catastrophic.

Upside case (35% CAGR, 15x exit): 3,69x MOIC, 29,9% IRR → excellent.

Investment Thesis Summary

Why Invest:

1. 01Best-in-class unit economics: CAC Payback 9 mesi, LTV/CAC 12,8x, Burn Multiple 0,12x → capital-efficient growth rarissimo per Series B.
2. 02Top-quartile retention: NRR 108%, churn 9% → strong product-market fit, revenue quality alta.
3. 03Clear path to Rule of 40: Attualmente 32, ma con marginal S&M optimization (10pp cut) → 41+ entro 18 mesi.
4. 04Defensible niche: HR predictive analytics è sub-vertical non ancora saturato. Incumbents (Workday/SAP) hanno analytics ma non prediction. Prisma ha 18-24 mesi lead.
5. 05EU-first advantage: GDPR-native, data residency, local sales → friction per US competitors entrare EU enterprise.

Key Risks:

1. 01Growth deceleration: 50% → 35% negli ultimi 12 mesi. Se continua trend (35% → 25%), valuation compresses.
2. 02Incumbent competition: Workday/SAP buildano predictive in-house → commoditize il mercato.
3. 03TAM ceiling: Mid-market EU HR analytics è €2,5B TAM ma realistico TAM ~€500M (penetration 20%) → Prisma ceiling €50-100M ARR.
4. 04Churn concentration: SMB churn 18% è alto. Se mix customer shift verso SMB (per accelerare growth), blended churn sale → NRR scende.

Mitigants:

• •Growth: Reinvest €2M dei €8M raise in S&M (+6 AE) → re-accelerate a 45-50% growth.
• •Competition: Deepen Workday integration (become "powered by Prisma" → co-sell motion).
• •TAM: Expand product (recruiting analytics, comp benchmarking) → TAM 3x.
• •Churn: Shift GTM upmarket (target €50K+ ACV mid-market) → churn scende a 6%.

Final Recommendation

INVEST — Series B €8M @ €42M post (10x ARR).

Rationale: Prisma combina unit economics eccezionali (top 5% SaaS) con retention top-quartile e path chiaro a Rule of 40. Growth è below median ma deliberatamente capital-efficient — questo è strategically sound per Series B dove profitability path conta quanto hypergrowth.

Valuation 10x ARR è fair (comps-adjusted). Risk/reward è favorevole: downside limitato (-30% worst case), upside significativo (+50-100% bull case).

Conditions:

1. 01Growth acceleration commitment: Management commit a re-accelerate growth a 45-50% nei prossimi 12 mesi usando €2M raise per S&M hiring.
2. 02NRR methodology transparency: Richiedi cohort-level NRR data ogni quarter. Se NRR scende <105%, trigger discussion su churn mitigation.
3. 03Competitive monitoring: Quarterly update su Workday/SAP product roadmap (predictive analytics). Se incumbents lanciano competing product, revisit thesis.

Next Steps:

• •[ ] Term sheet: €8M Series B, €42M post, 1x liquidation preference, standard anti-dilution
• •[ ] DD deep-dive: Customer calls (8-10 reference), churn analysis per cohort, sales pipeline review
• •[ ] Negotiate board seat + quarterly reporting cadence